Keywords: Roche, Cancer R&D, CPRIT, Strategic partnership

Roche takes academia route, linking with CPRIT to advance cancer R&D pipeline

Article | 08 July 2011

Print This

Swiss drug major Roche (ROG: SIX) today announced a strategic partnership agreement with the USA’s Cancer Prevention and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in